• 1. Fullerene tectonics. Part 2.1 Synthesis and pyrolysis of halogenated benzo[c]phenanthrenes
  M. John Plater J. Chem. Soc. Perkin Trans. 1 1997 2903
• 2. Fullerene tectonics. Part 1. A programmed precursor to C60
  M. John Plater J. Chem. Soc. Perkin Trans. 1 1997 2897
• 3. Electrophilic aromatic substitution. Part XV. Protiodetritiation of the helicene, benzo[c]phenanthrene
  Jean Le Guen,Roger Taylor J. Chem. Soc. Perkin Trans. 2 1974 1274

Recent Advances in the Study of (Naphthalen-2-ylmethyl)triphenyl-phosphonium bromide (CAS: 35160-95-3) in Chemical Biology and Medicine

(Naphthalen-2-ylmethyl)triphenyl-phosphonium bromide (CAS: 35160-95-3) is a phosphonium salt that has garnered significant attention in recent years due to its potential applications in chemical biology and medicine. This compound, characterized by its unique structure combining a naphthalene moiety with a triphenylphosphonium group, has been explored for its role in mitochondrial targeting, anticancer activity, and as a building block in organic synthesis. Recent studies have highlighted its utility in drug delivery systems, particularly in targeting cancer cells, owing to its ability to accumulate in mitochondria, which are critical for energy production and apoptosis regulation.

One of the key areas of research involving (Naphthalen-2-ylmethyl)triphenyl-phosphonium bromide is its application in cancer therapy. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits selective cytotoxicity against various cancer cell lines, including breast and lung cancer cells. The study revealed that the compound's mitochondrial-targeting capability enhances its efficacy in inducing apoptosis, while minimizing damage to healthy cells. This selectivity is attributed to the higher mitochondrial membrane potential in cancer cells, which facilitates the accumulation of the phosphonium salt.

In addition to its anticancer properties, (Naphthalen-2-ylmethyl)triphenyl-phosphonium bromide has been investigated for its role in neurodegenerative diseases. A recent preprint on bioRxiv reported that this compound could mitigate oxidative stress in neuronal cells by scavenging reactive oxygen species (ROS). The study suggested that the naphthalene moiety contributes to the compound's antioxidant activity, while the phosphonium group ensures its localization within mitochondria, where oxidative damage is most prevalent. These findings open new avenues for developing therapies for conditions such as Alzheimer's and Parkinson's diseases.

From a synthetic chemistry perspective, (Naphthalen-2-ylmethyl)triphenyl-phosphonium bromide serves as a versatile intermediate. A 2022 publication in Organic Letters detailed its use in the synthesis of complex organic molecules, including fluorescent probes and photosensitizers. The compound's stability and reactivity make it suitable for various coupling reactions, enabling the construction of diverse molecular architectures. Researchers have also exploited its phosphonium group for developing ionic liquids with applications in green chemistry and catalysis.

Despite these promising developments, challenges remain in optimizing the pharmacokinetics and bioavailability of (Naphthalen-2-ylmethyl)triphenyl-phosphonium bromide. Recent efforts have focused on modifying its structure to improve solubility and reduce potential toxicity. For instance, a 2023 patent application disclosed derivatives of this compound with enhanced water solubility, achieved by introducing polar substituents on the naphthalene ring. Such innovations are critical for advancing its clinical translation.

In conclusion, (Naphthalen-2-ylmethyl)triphenyl-phosphonium bromide (CAS: 35160-95-3) represents a multifaceted tool in chemical biology and medicine, with applications ranging from cancer therapy to neurodegenerative disease research. Ongoing studies continue to uncover its potential, while structural modifications aim to address existing limitations. As research progresses, this compound is poised to play an increasingly important role in the development of targeted therapies and advanced materials.

• 10273-74-2(Phosphonium,1,1'-[1,3-phenylenebis(methylene)]bis[1,1,1-triphenyl-, bromide (1:2))
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)